Main competitors
P/E (Y) Price to Book (Y) PEG (Y) EV / Sales (Y) EV / EBITDA (Y) EV / EBIT (Y) Dividend Yield (Y) Capi.($)
17.62x4.23x0.23x6.39x14.06x15.36x1.69% 4.43TCr
47.29x7.41x2.29x11.15x40.2x41.07x0.02% 5.09TCr
-25.47x74.3x-5.51x51.26x-29.11x-27.47x-.--% 3.17TCr
-26.94x1.24x-1.15x4.61x-12.72x-10.03x-.--% 2.74TCr
30.57x3.12x0.57x6.64x18.4x22.96x-.--% 2.19TCr
15.96x3.07x-5.59x3.7x9.79x10.35x-.--% 1.84TCr
-181.52x21.73x-2.07x44.77x-181.02x-159.81x-.--% 1.31TCr
-317.95x10.89x6.21x25x1052.16x-318.83x-.--% 1.24TCr
-11.54x - -0.04x144.19x-22.48x-11.31x-.--% 1.18TCr
14.17x3.17x1.58x3.77x8.93x10.06x-.--% 1.12TCr
-45.06x19.26x0.88x10.96x-38.14x-41.05x-.--% 1.09TCr
-17.81x16.03x-0x17.27x-21.64x-17.06x-.--% 861.9Cr
53.2x8.23x0.76x15.95x48.07x50.71x0.18% 853.92Cr
-10.51x-14.62x-0.51x95.14x-12.88x-12.6x-.--% 816.73Cr
-18.03x7.77x-0.4x - -18.51x-17.88x-.--% 801.03Cr
-9.97x - -0.22x - -9.18x-8.74x-.--% 794.58Cr
-148.66x16.2x1.81x16.51x555.7x-5144.5x-.--% 748.41Cr
-22000x45.58x221.63x114.9x-1716.86x-1161.52x - 713.9Cr
Average -1,257.48x 14.23x 12.25x 35.76x -17.51x -376.68x 0.11% 1.72TCr
Weighted average by Cap. -523.96x 14.95x 4.84x 25.76x 12.51x -164.63x 0.26%
Bio Therapeutic Drugs